Home
About Us
Management Team
Board of Directors
Science Advisory Board
News
Product Platform & Pipeline
Scientific Foundation
Journal Articles
ATB-429:
Inflammatory Bowel Disease
(IBD)
ATB-346: Acute and Chronic Joint Pain
ATB-284: Irritable Bowel Syndrome (IBS)
Contact Us
Intranet Portal
Our Team
Board of Directors
Andre G. Buret, PhD
Calgary, Canada
Vice President Research, Antibe Therapeutics
Professor of Biological Sciences at the University of Calgary.
Roderick J. Flower, PhD
London, UK
Deputy Director, Centre for Biochemical Pharmacology, William Harvey Research Institute;
Fellow of the Royal Society;
Past-President, British Pharmacological Society
Louis J. Ignarro, PhD
Los Angeles, USA
1998 Nobel Prize for Medicine/Physiology;
Department of Molecular and Medical Pharmacology, UCLA
George Jackowski, PhD
Toronto, Canada
Chairman, Phoenix Group of Companies, Toronto;
Chief Science Officer, Nanogen Inc.; Co-Founder, Spectral Diagnostics;
Dan Legault, LLB
Toronto, Canada
President and CEO, Antibe Therapeutics
Daniel K. Podolsky, MD
Dallas, USA
President, University of Texas Southwestern;
Board of Director, Glaxo Smith Kline;
Past-President, American Gastroenterological Association (AGA)
John L. Wallace, PhD, MBA
Toronto, Canada
Founder and Chief Science Officer, Antibe Therapeutics
Co-Founder, NicOx S.A.
Professor of Medicine at the McMaster University